|Home||» Products||» Breast Cancer Medicine||» Lapatinib ditosylateTablet|
Tykerb Tablet is used for the treatment of advanced or metastatic breast cancer.Tykerb (chemical name: lapatinib) has been approved by the U.S. Food and Drug Administration (FDA):
to be given in combination with , a type of chemotherapy, to treat advanced-stage, HER2-positive breast cancer that has stopped responding to anthracyclines, taxanes.
Generic Name: Lapatinib
Available in: 250 mg